Scroll
To Top

December 16, 2013

TOPIC: Advocacy, Featured News, Industry, Medical, Patients & Members

Genzyme and NORD Establish Program to Help Undiagnosed Patients with Rare Diseases

Posted at December 12, 2013 08:39 pm by Mary Dunkle

CAMBRIDGE, MA and DANBURY, CT—-Genzyme, a Sanofi company, and the National Organization for Rare Disorders (NORD) today announced the creation of a fund to pay for standard diagnostic testing for people with mysterious, undiagnosed medical conditions.  The fund will help those who have applied to the National Institutes of Health (NIH) Undiagnosed Diseases Program but who cannot afford the… Read More

October 23, 2013

TOPIC: Advocacy, Featured News, Medical, Patients & Members

30 Years After the Orphan Drug Act: It Still Takes Too Long for People with Rare Diseases to Get an Accurate Diagnosis

Posted at October 10, 2013 02:44 pm by Mary Dunkle

 

NORD recently posted the following question on its Facebook page: How long did it take you or a loved one to get an accurate diagnosis?

We were stunned at the response. Within the first few hours, we got 200 replies and 20% of those who responded had waited 10 years or longer to get an accurate… Read More

August 29, 2013

TOPIC: Advocacy, Featured News, Patients & Members

Enrollment in Your Health Insurance Marketplace

Posted at August 8, 2013 03:27 pm by Paul Melmeyer

 

It seems like just yesterday the Supreme Court handed down its controversial decision to uphold much of President Obama’s monumental healthcare reform bill, the Affordable Care Act. But with just a little over a month until the health insurance marketplaces open for enrollment on October 1st, it is now more important than ever to understand how healthcare reform affects… Read More